Recent news coverage highlights mixed revenue trends for Planet 13, with a reported 14% revenue decline in Q2 2025 followed by reports of revenue growth amid operational challenges.

• Planet 13 reported a 14% revenue decline in Q2 2025, indicating short-term sales pressure [N2].
• Subsequent news reports indicate revenue growth amid challenges, suggesting some operational resilience [N1].

Planet 13’s diversified license portfolio and multi-state operations provide a platform for capturing market share in the evolving U.S. cannabis industry. Its proprietary brands and large customer base support product differentiation and customer retention. The company’s vertical integration enables control over product quality and supply chain efficiencies. Recent reports of revenue growth amid challenges suggest operational resilience.

The company faces significant regulatory, legal, and operational risks inherent in the cannabis industry, including licensing challenges, compliance costs, and federal illegality in the U.S. Financial results show sustained net losses and negative EPS, indicating ongoing profitability challenges. Market competition and potential supply chain disruptions may impact growth. Liquidity ratios suggest moderate short-term financial flexibility but limited cash reserves. Revenue volatility is evident from recent mixed news reports.

Planet 13’s moat derives from its vertically integrated business model spanning cultivation, production, distribution, and retail across multiple regulated U.S. states. Its portfolio of licenses, established retail locations including a flagship superstore, proprietary product brands, and a large customer loyalty database provide competitive advantages. The company’s multi-state presence and operational scale support market access and brand recognition in a highly regulated and competitive cannabis industry.

• Regulatory and Legal Risks: Planet 13 operates in a highly regulated industry with complex and evolving state and federal laws. Non-compliance or changes in regulations could materially impact operations and financial results [S1].
• Financial Performance and Liquidity Risks: The company reported a net loss of approximately $63.9 million in fiscal 2025 and has limited cash reserves relative to liabilities, which may constrain operational flexibility and growth [S1].
• Market and Competitive Risks: Competition from other licensed cannabis operators and third-party delivery services may affect market share and pricing. The company’s ability to maintain and grow its customer base is critical [S1].
• Supply Chain and Operational Risks: Dependence on key inputs, suppliers, and operational licenses exposes the company to risks of supply disruptions and increased costs [S1].
• Federal Illegality and Financial Access Risks: Cannabis remains federally illegal in the U.S., which may restrict access to banking, capital markets, and increase compliance burdens [S1].

• Planet 13 Holdings Inc. is a vertically integrated cannabis cultivator and provider operating in Nevada, California, Illinois, and Florida [S1].
• The company holds multiple licenses in Nevada: six cultivation licenses (three medical, three adult-use), six production licenses (three medical, three adult-use), three dispensary licenses (one medical, two adult-use), and one distribution license covering adult-use and medicinal cannabis [S1].
• In California, subsidiaries hold one medium indoor cultivation license, one manufacturing license, two distribution licenses, one dispensary license, and one event organizer license [S1].
• In Florida, the company operates under a Medical Marijuana Treatment Center license allowing unlimited medical dispensaries (33 locations as of 2025-12-31), multiple cultivation facilities (one operational), and multiple manufacturing facilities (one operational) [S1].
• In Illinois, the company holds one adult-use dispensing license [S1].
• Planet 13 owns and manufactures cannabis products under brands including HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (flower, vapes, concentrates), Medizin (flower, vapes, concentrates), and Leaf and Vine (flower and vapes) [S1].
• The company has a customer loyalty database exceeding 485,000 customers [S1].
• Planet 13 operates the Planet 13 Las Vegas Superstore, a 24,000 square foot dispensary near the Las Vegas Strip, serving medical and retail customers with entertainment features and a consumption lounge [S1].
• The company also operates the Medizin dispensary in Nevada, the Planet 13 OC Superstore dispensary in Santa Ana, California, and the Planet 13 dispensary in Waukegan, Illinois [S1].
• In Florida, the company operates 33 medical dispensaries totaling over 80,000 square feet of retail space [S1].
• The company’s 2025 fiscal year revenue was approximately $103.4 million USD, with a net loss of about $63.9 million USD and basic EPS of -$0.20 per share [S1].
• As of 2025-12-31, Planet 13 had cash and cash equivalents of approximately $5.3 million USD, current assets of about $41.1 million USD, current liabilities of about $23.1 million USD, a current ratio of 1.78, and a cash ratio of 0.23 [S1].
• The company’s business is subject to regulatory compliance and operational risks typical of the cannabis industry, including licensing, supply chain, and legal risks [S1].
• Recent news indicates mixed revenue trends: a 14% revenue drop in Q2 2025 and subsequent reports of revenue growth amid challenges [N2][N1].